Restoring infant nose bacteria after staph treatment
Part of Infections clinical trials.
This study tests whether giving a nasal spray of healthy bacteria to infants can restore good germs in the nose after they receive mupirocin ointment to treat Staph aureus. It aims to bring back a healthy nasal microbiome.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have had a Staph aureus infection found on a nasal swab in the past
- Your child must be under 18 years old
- Your child must have finished mupirocin nose ointment at least 2 days ago and be staying in the hospital for over 3 more days after that
- You will need a healthy donor (like a parent or other caregiver) who does not have Staph in their nose and is not sick with a cold or flu
- Infants younger than 2 months must have been born at more than 25 weeks of pregnancy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving one versus multiple doses of a special nasal treatment (called nasal microbiota therapy, or NMT) changes the types of helpful bacteria in your baby's nose. The goal is to see if the treatment keeps bad bacteria, like staph, from growing.
This trial tests whether giving a small dose of the mother's vaginal bacteria to babies born by C-section can help restore their gut microbiome. It may reduce the risk of allergies and other immune-related conditions later in life.
This study tests whether giving a baby’s own stool back to them (after it was stored before antibiotics) can help restore healthy gut bacteria. It’s for healthy infants and toddlers up to 4 years old who haven’t recently taken antibiotics.
This study looks at whether they can safely place “healthy vaginal bacteria” from the mother into the newborn after a scheduled C-section, and whether it improves the baby’s health. It only enrolls certain mothers and babies based on infection testing and other health factors.
This trial tests if transplanting healthy nasal bacteria from a donor can help people with chronic sinusitis. It aims to restore a healthy microbiome in the nose to reduce symptoms like congestion and discharge.
This trial tests a new nose spray called HY-133 to see if it's safe and can clear a common type of staph bacteria from the nose. It is for people who have this bacteria but not the antibiotic-resistant kind.
Hear when a new Microbial Colonization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.